• Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
  • Industry
  • Finance
  • Culture
  • Politics
  • Science
  • Wellness
Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.
AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy
Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy
Two New Studies Are Rewriting the Rules of Psychedelic Drug Development
Starting 2026: Why Neuroplastogens Are Quietly Redefining the Psychedelic Medicine Narrative
Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward
Delix Therapeutics Reports Strong Phase Ib Results
Childhood Trauma’s Role in Men’s Substance Use Disorders
Human-Centered AI in Healthcare
Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up
Shop

Psychedelic Retreat Group Kaivalya Kollectiv Welcomes The Conscious Fund onto Advisory Board

Microdose by Microdose
September 16, 2021
in Press Releases
Reading Time: 2 mins read
A A

In the booming era of the psychedelic renaissance, there are many options for undergoing a psychedelic experience, from ketamine clinics to MDMA assisted therapy, underground ceremonies, and of course one of the most popular methods is the retreat setting. For many, the multi-day container of a retreat allows them the proper space to undergo the type of work that can be expected from the psychedelic experience. One of the leaders in the retreat space has been Kaivalya Kollectiv’s “Tandava Retreats”, run by Founder, CEO, and 5-MeO-DMT facilitator Joel Brierre.

Joel Brierre has been a pioneer in the modern psychedelic movement, specifically in the realm of 5-MeO-DMT and the Bufo Alvarius toad. His unique approach of applying classical non-dual yogic philosophy as geography for both preparation and integration from the entheogenic experience gained attention around the world at the first WBAC (World Bufo Alvarius Congress) in 2018 and continues to shift the landscape of psychedelic use.

Kaivalya Kollectiv

Joel and the Tandava team are opening the world’s first 5-MeO-DMT retreat center in beautiful Tepoztlan, Mexico in November of 2021 and will be welcoming participants to come and book a 3, 5, or 7-day personalized retreat. Following shortly after, they will be opening their Costa Rica location in partnership with Hive Bio in mid-2022. Kaivalya Kollectiv’s subsidiary companies include Tandava retreats, F.I.V.E. Education platform, and an upcoming app called Gnosis.

[bsa_pro_ad_space id=2]
ADVERTISEMENT

As it expands its footprint, it is now welcoming The Conscious Fund onto their advisory board. “We are honored to have guidance from an industry powerhouse like The Conscious Fund, we’re expanding quicker than we had ever thought, who better to help shape this growth than TCF” says founder and CEO Joel Brierre.

Continue on your trip...

AbbVie’s $1B Psychedelic Bet: Who’s Next in the Neuroplastogen Gold Rush?

Enveric’s Latest Patent Signals a Clear Path Forward for PTSD Drug Development

Enveric’s EB-003 Shows Promise in PTSD Model, Offering a New Direction in Trauma Treatment

Founding partner Henri Sant-Cassia commented “Joel and his team have shown deep understanding of psychedelic wellness, luxury hospitality and brand building, and we see them becoming the international leader in this expanding sector. We are delighted to be helping accelerate their growth”.

About The Conscious Fund

Purchase Lasix Immediately

The Conscious Fund is the most active early-stage venture fund in the psychedelic medicine space. It invests into drug discovery, clinics, addiction programs, retreats, AI, telemedicine, media and training. Its global, platform based approach helps to transform outcomes for patients with mental health, addiction and chronic pain issues.

Contact: Henri Sant-Cassia
Phone: +44 7411-033-109
Email: henri@theconscious.fund
Web: https://www.theconscious.fund

About Kaivalya Kollectiv

The Tandava team is raising the bar for psychedelic and wellness retreats, working in breathtakingly beautiful settings around the world, and led by top notch teachers and facilitators with extensive experience. Safety is the number one priority, followed closely by a warm and welcoming container that is both nurturing and expansive.

Contact: Joel Brierre
Phone: +1 305-731-0932
Email: joel@kaivalyakollectiv.com
Web: https://kaivalyakollectiv.com

[bsa_pro_ad_space id=2]
ADVERTISEMENT
Tags: Kaivalya KollectivThe Conscious Fund
Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Next Post
Psychedelic Titans with Kathryn Tucker of Emerge Law Group

Psychedelic Titans with Kathryn Tucker of Emerge Law Group

Who do you think will be first to successfully develop a psychedelic drug?
This field is for validation purposes and should be left unchanged.

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

ADVERTISEMENT

Follow us on social

Microdose is your guide to psychedelics. Our mission is to shift the world’s perception of psychedelic medicine.

Read the News
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
  • Industry
  • Culture
  • Science
  • Finance
  • Law & Politics
  • Health & Wellness
Online Courses
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
  • Microdosing
  • MDMA
  • Ketamine
  • Psychedelic Counseling
  • Addiction Treatment
  • Classic Psychedelics
Subscribe for Exclusive Updates

Terms & Conditions / Privacy Policy

© 2026 MD Media Inc. All rights reserved. The information provided on this website does not, and is not intended to, constitute financial, legal or medical advice. All information, content, and materials available on this site are for general educational and informational purposes only.

WordPress Ads
No Result
View All Result
  • Landing Page
  • Buy JNews
  • Support Forum
  • Contact Us

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.